{"id":"flulavaltm-yb","safety":{"commonSideEffects":[{"rate":"10–30%","effect":"Injection site soreness or erythema"},{"rate":"5–15%","effect":"Myalgia"},{"rate":"5–10%","effect":"Headache"},{"rate":"5–10%","effect":"Fatigue"},{"rate":"<5%","effect":"Low-grade fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated (killed) influenza virus antigens representing two influenza A strains and two influenza B strains. Upon administration, it triggers both humoral (antibody) and cellular immune responses, enabling the body to recognize and neutralize circulating influenza viruses before infection occurs. This provides seasonal protection against the included viral strains.","oneSentence":"FluLaval-YB is a quadrivalent inactivated influenza vaccine that stimulates immune response against four strains of influenza virus.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:12:55.146Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention in adults and children"}]},"trialDetails":[{"nctId":"NCT01196975","phase":"PHASE3","title":"A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-10-01","conditions":"Influenza","enrollment":1707}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["FluLavalTM containing the Yamagata B flu strain","FluLaval®-YB"],"phase":"phase_3","status":"active","brandName":"FluLavalTM-YB","genericName":"FluLavalTM-YB","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Biologic","firstApprovalDate":"","aiSummary":"FluLaval-YB is a quadrivalent inactivated influenza vaccine that stimulates immune response against four strains of influenza virus. Used for Seasonal influenza prevention in adults and children.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}